SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shilpa Medicare - Quaterly Results

23 May 2026 Evaluate
The turnover is pegged at Rs. 2011.10 millions for the March 2026 quarter. The mentioned figure indicates a rise of about 59.35% as against Rs. 1262.10 millions during the year-ago period.The Total Profit for the quarter ended March 2026 of Rs. 709.60 millions grew from Rs.-56.30 millionsOperating Profit saw a handsome growth to 666.80 millions from 486.60 millions in the quarter ended March 2026.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 2011.10 1262.10 59.35 5970.30 4774.10 25.06 5970.30 4774.10 25.06
Other Income 68.90 106.40 -35.24 381.40 696.70 -45.26 381.40 696.70 -45.26
PBIDT 666.80 486.60 37.03 1938.60 2058.00 -5.80 1938.60 2058.00 -5.80
Interest 26.20 19.10 37.17 100.40 58.70 71.04 100.40 58.70 71.04
PBDT 924.30 24.30 3703.70 2032.40 1541.90 31.81 2032.40 1541.90 31.81
Depreciation 144.10 123.40 16.77 551.10 488.60 12.79 551.10 488.60 12.79
PBT 780.20 -99.10 -887.29 1481.30 1053.30 40.63 1481.30 1053.30 40.63
TAX 70.60 -42.80 -264.95 151.60 374.40 -59.51 151.60 374.40 -59.51
Deferred Tax 13.80 -59.40 -123.23 76.60 -96.40 -179.46 76.60 -96.40 -179.46
PAT 709.60 -56.30 -1360.39 1329.70 678.90 95.86 1329.70 678.90 95.86
Equity 195.60 97.80 100.00 195.60 97.80 100.00 195.60 97.80 100.00
PBIDTM(%) 33.16 38.55 -14.00 32.47 43.11 -24.68 32.47 43.11 -24.68

Shilpa Medicare Share Price

546.20 7.30 (1.35%)
12-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1807.25
Dr. Reddys Lab 1273.90
Cipla 1388.80
Zydus Lifesciences 1104.35
Lupin 2292.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: